Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin‑resistant human epidermal growth factor receptor 2‑positive breast cancer

Junjun Liu(Qingdao University), Jing Han(Shanghai East Hospital)
Oncology Letters
July 14, 2021
Cited by 22


Related Papers